These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 8447439)

  • 1. Thromboxane binding and signal transduction in rat glomerular mesangial cells.
    Spurney RF; Onorato JJ; Albers FJ; Coffman TM
    Am J Physiol; 1993 Feb; 264(2 Pt 2):F292-9. PubMed ID: 8447439
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of rat glomerular thromboxane A2 receptors: comparison to rat platelets.
    Folger WH; Halushka PV; Wilcox CS; Guzman NJ
    Eur J Pharmacol; 1992 Sep; 227(1):71-8. PubMed ID: 1426024
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 7-[(1R,2S,3S,5R)-6,6-dimethyl-3-(4- iodobenzenesulfonylamino)bicyclo[3.1.1]hept-2-yl]-5(Z)-heptenoic acid: a novel high-affinity radiolabeled antagonist for platelet thromboxane A2/prostaglandin H2 receptors.
    Naka M; Mais DE; Morinelli TA; Hamanaka N; Oatis JE; Halushka PV
    J Pharmacol Exp Ther; 1992 Aug; 262(2):632-7. PubMed ID: 1386885
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of a thromboxane A2/prostaglandin H2 receptor in guinea pig lung membranes using a radioiodinated thromboxane mimetic.
    Saussy DL; Mais DE; Dubé GP; Magee DE; Brune KA; Kurtz WL; Williams CM
    Mol Pharmacol; 1991 Jan; 39(1):72-8. PubMed ID: 1824791
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Binding and function of a potent new thromboxane receptor antagonist, BMS 180,291, in human platelets.
    Webb ML; Liu EC; Monshizadegan H; Hedberg A; Misra RN; Goldenberg H; Harris DN
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1387-94. PubMed ID: 8450473
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of the vascular thromboxane A2/prostaglandin endoperoxide receptor in rabbit aorta. Regulation by dexamethasone.
    Sessa WC; Halushka PV; Okwu A; Nasjletti A
    Circ Res; 1990 Dec; 67(6):1562-9. PubMed ID: 2147131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The response to thromboxane A2 analogues in human platelets. Discrimination of two binding sites linked to distinct effector systems.
    Takahara K; Murray R; FitzGerald GA; Fitzgerald DJ
    J Biol Chem; 1990 Apr; 265(12):6836-44. PubMed ID: 2139029
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effect of pH on thromboxane A2/prostaglandin H2 receptor agonist and antagonist binding in human platelets.
    Mayeux PR; Morinelli TA; Williams TC; Hazard ES; Mais DE; Oatis JE; Baron DA; Halushka PV
    J Biol Chem; 1991 Jul; 266(21):13752-8. PubMed ID: 1830308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of thromboxane receptor activation in rat glomerular mesangial cells.
    Spurney RF; Middleton JP; Raymond JR; Coffman TM
    Am J Physiol; 1994 Sep; 267(3 Pt 2):F467-78. PubMed ID: 8092261
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet and vascular thromboxane A2/prostaglandin H2 receptors. Evidence for different subclasses in the rat.
    Masuda A; Mais DE; Oatis JE; Halushka PV
    Biochem Pharmacol; 1991 Jul; 42(3):537-44. PubMed ID: 1830482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dissociation of the contractile and hypertrophic effects of vasoconstrictor prostanoids in vascular smooth muscle.
    Dorn GW; Becker MW; Davis MG
    J Biol Chem; 1992 Dec; 267(34):24897-905. PubMed ID: 1447225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homologous desensitization of human platelet thromboxane A2/prostaglandin H2 receptors.
    Okwu AK; Ullian ME; Halushka PV
    J Pharmacol Exp Ther; 1992 Jul; 262(1):238-45. PubMed ID: 1378092
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mechanism for homologous downregulation of thromboxane A2 receptors in cultured human chronic myelogenous leukemia (K562) cells.
    Dorn GW
    J Pharmacol Exp Ther; 1991 Oct; 259(1):228-34. PubMed ID: 1833525
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cloning and pharmacologic characterization of a thromboxane A2 receptor from K562 (human chronic myelogenous leukemia) cells.
    D'Angelo DD; Davis MG; Ali S; Dorn GW
    J Pharmacol Exp Ther; 1994 Nov; 271(2):1034-41. PubMed ID: 7965765
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of ligand binding to thromboxane A2/prostaglandin H2 receptors by diethylpyrocarbonate. Protection by receptor ligands and reversal by hydroxylamine.
    Schrör K; Davis-Bruno K; Halushka PV
    Biochem Pharmacol; 1995 Mar; 49(7):921-7. PubMed ID: 7741764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of an 125I-labeled thromboxane A2/prostaglandin H2 receptor agonist.
    Morinelli TA; Oatis JE; Okwu AK; Mais DE; Mayeux PR; Masuda A; Knapp DR; Halushka PV
    J Pharmacol Exp Ther; 1989 Nov; 251(2):557-62. PubMed ID: 2530338
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interspecies differences in thromboxane receptors: studies with thromboxane receptor antagonists in rat and guinea pig smooth muscles.
    Ogletree ML; Allen GT
    J Pharmacol Exp Ther; 1992 Feb; 260(2):789-94. PubMed ID: 1531361
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostaglandin I2 mediates contraction and relaxation of vascular smooth muscle.
    Williams SP; Dorn GW; Rapoport RM
    Am J Physiol; 1994 Aug; 267(2 Pt 2):H796-803. PubMed ID: 8067435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in vascular responsiveness to a thromboxane mimetic in endotoxin tolerance.
    Tempel GE; Brown AN; Morinelli TA; Halushka PV; Cook JA
    Shock; 2001 Nov; 16(5):389-92. PubMed ID: 11699079
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of protein kinase C reduces thromboxane receptors in glomeruli and mesangial cells.
    Studer RK; Craven PA; DeRubertis FR
    Kidney Int; 1993 Jul; 44(1):58-64. PubMed ID: 8355467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.